Seshadri Neervannan serves as Executive at Tarsus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Seshadri Neervannan has executed 11 insider transactions totaling $178.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 16, 2025 involved gifting 950 shares valued at $0.
Seshadri Neervannan currently holds 79,183 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Seshadri Neervannan has been a net seller of TARS stock. They have purchased $0 and sold $178.0K worth of shares.
Seshadri Neervannan's most recent insider trade was on Dec 16, 2025, when they sold 950 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 18, 2024 | TARS | $149.3K | Sale | 4,879 | $30.60 | Discretionary |
| Mar 15, 2024 | TARS | $0 | Option Exercise | 13,245 | $N/A | Discretionary |
| Mar 23, 2023 | TARS | $4.7K | Sale | 390 | $12.15 | Discretionary |
| Mar 22, 2023 | TARS | $4.8K | Sale | 379 | $12.64 | Discretionary |
| Mar 21, 2023 | TARS | $4.8K | Sale | 372 | $12.89 | Discretionary |
| Mar 20, 2023 | TARS | $4.8K | Sale | 380 | $12.61 | Discretionary |
| Mar 17, 2023 | TARS | $4.8K | Sale | 360 | $13.28 | Discretionary |
| Mar 16, 2023 | TARS | $4.8K | Sale | 357 | $13.43 | Discretionary |
| Mar 15, 2023 | TARS | $0 | Option Exercise | 5,097 | $N/A | Discretionary |